Summary of Study ST001120
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000751. The data can be accessed directly via it's Project DOI: 10.21228/M8M676 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST001120 |
| Study Title | Reprogrammed Lipid Metabolism in Bladder Cancer with Cisplatin Resistance |
| Study Summary | This study conducted comprehensive and comparative lipidomic profiling of two isogenic human T24 bladder cell lines, which are characterized as sensitive or resistant to the cisplatin-induced cell apoptosis. |
| Institute | Cedars-Sinai Medical Center |
| Department | Departments of Surgery and Biomedical Sciences |
| Last Name | Kim |
| First Name | Jayoung |
| Address | 8700 Beverly Blvd., Davis 5071 Los Angeles, CA 90048, USA |
| Jayoung.Kim@cshs.org | |
| Phone | 310-423-7168 |
| Submit Date | 2017-04-10 |
| Study Comments | Treatment with ACSS1 inhibitor |
| Analysis Type Detail | LC-MS |
| Release Date | 2019-03-06 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Collection:
| Collection ID: | CO001171 |
| Collection Summary: | T24 BC cells were obtained and cultured, according to instructions provided by the ATCC. Media was supplemented with 10% fetal bovine serum, 2% glutamine and 1% antibiotics (Invitrogen, Carlsbad, CA). Cells were maintained under a humidified atmosphere of 5% CO2 at 37°C. These cell lines were negative for mycoplasma and all other infectious agents evaluated. |
| Sample Type: | Cultured cells |
